Please login to the form below

Not currently logged in
Email:
Password:

BMS’ Brian Daniels to retire

He will step down from role as senior VP, global development and medical affairs
BMS Brian Daniels

Dr Brian Daniels is to retire from his role as senior VP, global development and medical affairs at Bristol-Myers Squibb (BMS) on July 1, 2014.

Dr Daniels has been with BMS since 2000 as VP of the immunology, pulmonary, and dermatology therapeutic area where he worked on such compounds as rheumatoid arthritis drug Orencia (abatacept). He took on his current role in 2008.

Francis Cuss, executive vice president and chief scientific officer, BMS said: "He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb."

Prior to joining BMS, Dr Daniels spent four years at Merck Research Laboratories in clinical research where he ultimately assumed the role of senior director, pulmonary and immunology. He has also worked in clinical research at Genentech.

7th May 2014

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics